major histocompatibility complex, class II, DR beta 4
| GO Term | Evidence Code | PMID |
|---|---|---|
| adaptive immune response |
|
|
| peptide antigen assembly with MHC class II protein complex |
|
|
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
|
|
| immune response |
|
|
| antigen processing and presentation |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| Golgi membrane |
|
|
| lysosomal membrane |
|
|
| lysosomal membrane |
|
|
| lysosomal membrane |
|
|
| lysosomal membrane |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| MHC class II protein complex binding |
|
|
| peptide antigen binding |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0080822 | aspirin-induced respiratory disease |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026